Literature DB >> 2296475

Taurine and osmoregulation. III. Taurine deficiency protects against cerebral edema during acute hyponatremia.

H Trachtman1, R del Pizzo, J A Sturman.   

Abstract

Taurine is a cerebral osmoprotective molecule during chronic hypernatremic dehydration. In these experiments, we investigated the role of taurine in osmoregulation during acute hyponatremia. Taurine deficiency was induced in experimental cats (n = 6) by feeding a taurine-free diet for 8-10 wk, whereas control counterparts (n = 6) consumed a regular diet. Hyponatremia was provoked in all cats over 54 h by daily injections of 5% dextrose in water (7.5% body wt) and vasopressin (20 U/d). The serum Na+ concentration was abruptly lowered to 110 +/- 3 and 117 +/- 2 mmol/L, in experimental and control animals, respectively. The cerebral total and intracellular water compartment sizes were reduced from 486 +/- 11 to 441 +/- 11 ml/100 g dry wt and from 357 +/- 7 to 309 +/- 12 mL/100 g dry wt, respectively, in control versus experimental cats, p less than 0.05. There was a significant linear relationship between cerebral taurine content and the intracellular water compartment size in all animals, p less than 0.02. Taurine displayed a similar osmoprotective capacity in muscle tissue in these studies. We conclude that taurine is an osmoregulatory molecule in cerebral and extracerebral tissues during severe hyponatremia. Reductions in tissue taurine content may complement decreases in cytosolic electrolyte levels during adaptation to more prolonged hyponatremia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296475     DOI: 10.1203/00006450-199001000-00022

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  An in vitro paradigm for diabetic cerebral oedema and its therapy: a critical role for taurine and water channels.

Authors:  Ildi H Koves; Vincenzo C Russo; Sandra Higgins; Avantika Mishra; James Pitt; Fergus J Cameron; George A Werther
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

2.  Taurine: A therapeutic agent in experimental kidney disease.

Authors:  H Trachtman; J A Sturman
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

3.  Taurine as osmoregulator and neuromodulator in the brain.

Authors:  S S Oja; P Saransaari
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

4.  Comparative population genetic structure of redbelly tilapia (Coptodon zillii (Gervais, 1848)) from three different aquatic habitats in Egypt.

Authors:  Taha Soliman; Walid Aly; Reda M Fahim; Michael L Berumen; Holger Jenke-Kodama; Giacomo Bernardi
Journal:  Ecol Evol       Date:  2017-11-15       Impact factor: 2.912

Review 5.  Effect of taurine supplementation on growth and development in preterm or low birth weight infants.

Authors:  A Verner; S Craig; W McGuire
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.